AAAAAA
Results:
1-7
|
Results: 7
Authors:
CLIFTONBLIGH RJ
WENTWORTH JM
HEINZ P
CRISP MS
JOHN R
LAZARUS JH
LUDGATE M
CHATTERJEE VK
Citation: Rj. Cliftonbligh et al., MUTATION OF THE GENE ENCODING HUMAN TTF-2 ASSOCIATED WITH THYROID AGENESIS, CLEFT-PALATE AND CHOANAL ATRESIA, Nature genetics, 19(4), 1998, pp. 399-401
Authors:
BALAN KK
COLES AJ
WRAIGHT EP
CHATTERJEE VK
COMPSTON A
Citation: Kk. Balan et al., THYROID-DYSFUNCTION FOLLOWING ANTILYMPHOCYTE MONOCLONAL-ANTIBODY TREATMENT OF MULTIPLE-SCLEROSIS - SCINTIGRAPHIC ASSESSMENT, The Journal of nuclear medicine, 39(5), 1998, pp. 1156-1156
Authors:
MATTHEWS C
CHATTERJEE VK
Citation: C. Matthews et Vk. Chatterjee, ISOLATED DEFICIENCY OF FOLLICLE-STIMULATING-HORMONE REVISITED, The New England journal of medicine, 337(9), 1997, pp. 642-642
Authors:
ADAMS M
REGINATO MJ
SHAO DL
LAZAR MA
CHATTERJEE VK
Citation: M. Adams et al., TRANSCRIPTIONAL ACTIVATION BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA IS INHIBITED BY PHOSPHORYLATION AT A CONSENSUS MITOGEN-ACTIVATED PROTEIN-KINASE SITE, The Journal of biological chemistry, 272(8), 1997, pp. 5128-5132
Authors:
MONTAGUE C
PRINS JB
ADAMS M
HOLDER JC
SMITH SA
LAZAR M
SANDERS L
DIGBY J
SEWTER C
CHATTERJEE VK
ORAHILLY S
Citation: C. Montague et al., THIAZOLIDINEDIONES AND PGJ(2) HAVE DEPOT-SPECIFIC EFFECTS ON HUMAN PRE-ADIPOCYTE DIFFERENTIATION, Diabetes, 46, 1997, pp. 866-866
Authors:
WEETMAN AP
PICKERILL AP
WATSON P
CHATTERJEE VK
EDWARDS OM
Citation: Ap. Weetman et al., TREATMENT OF GRAVES-DISEASE WITH THE BLOCK-REPLACE REGIMEN OF ANTITHYROID DRUGS - THE EFFECT OF TREATMENT DURATION AND IMMUNOGENETIC SUSCEPTIBILITY ON RELAPSE, Quarterly Journal of Medicine, 87(6), 1994, pp. 337-341
Authors:
TONE Y
COLLINGWOOD TN
ADAMS M
CHATTERJEE VK
Citation: Y. Tone et al., FUNCTIONAL-ANALYSIS OF A TRANSACTIVATION DOMAIN IN THE THYROID-HORMONE BETA-RECEPTOR, The Journal of biological chemistry, 269(49), 1994, pp. 31157-31161
Risultati:
1-7
|